Click on icon to see table/diagram/imagePediatric Patients: Dolutegravir tablets may be taken with or without food.
Treatment-Naïve or Treatment-Experienced INSTI-Naïve: The recommended dose of dolutegravir tablets in pediatric patients weighing at least 30 kg is provided in Table 11. (See Table 11.)
Click on icon to see table/diagram/imageSafety and efficacy of dolutegravir tablets have not been established in pediatric patients who are INSTI-experienced with documented or clinically suspected resistance to other INSTIs (raltegravir, elvitegravir).
Sign Out